ESC Professional Premium Access

Basic and Translational Late-Breaking Science 2

Event: ESC Congress 2022
Topic: Basic Science
Session type: Basic and Translational Late-Breaking Science
Date: 29 August 2022
Time: 11:15 - 12:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.

Speaker: Doctor J. Lee (Yongin, KR)
Thumbnail

Ventricular Arrhythmic Risk Prediction in Low- and Moderate-risk Populations Using a Single-Lead ECG Heartbeat.

Speaker: Doctor J. Ramirez (Zaragoza, ES)
Thumbnail

The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Speaker: Assistant Professor G. Claessen (Leuven, BE)
Thumbnail

Precision approaches to defining susceptibility to atrial fibrillation determine risk of cardioembolic stroke.

Speaker: Doctor P. Gajendragadkar (Oxford, GB)
Thumbnail

4 speakers from this session

Doctor Ju-Hee Lee

Chong Kun Dang Pharm., Yongin (Korea (Republic of))
1 presentation
0 follower

Doctor Julia Ramirez

Aragon Institute of Engineering Research, Zaragoza (Spain)
1 presentation
0 follower

Assistant Professor Guido Claessen

University Hospitals (UZ) Leuven, Leuven (Belgium)
7 presentations
0 follower

Doctor Parag Ravindra Gajendragadkar

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk